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a b s t r a c t
An HCV outbreak occurred in 2012 in China, affecting hundreds of patients. We characterized HCV
subtype 2a and 6a sequences from 60 and 102 patients, respectively, and co-analyzed themwith 82 local
controls and 103 calibrating references. The close grouping of the patients' sequences contrasted sharply
with the diversity of local controls. Scaled by the calibrating references, the emergence of patients'
isolates was estimated at 2–5 years before sampling. In contrast, the controls intermingled with the
calibrating references that were much older. For both subtypes, the major and minor clusters could be
deﬁned, with the closeness to indicate linked transmission. Conclusion: HCV sequences from the study
patients grouped into three subtype 2a and two subtype 6a clusters, in addition to three 6a solitary
branches, representing descendants of eight earlier strains that were distinct and otherwise sporadic.
Due to iatrogenic transmission through reusing needles, ﬁve strains were highly selected and
preferentially spread.
& 2015 Published by Elsevier Inc.
Introduction
The analysis of genetic sequences has been effectively used to
characterize the source of infection and transmission routes in
outbreaks or linked cases caused by rapidly evolving RNA viruses,
such as hepatitis C virus (HCV) and human immunodeﬁciency
virus type 1 (HIV-1). Since 1992 a number of such studies have
been reported (Ou et al., 1992; Esteban et al., 1996; Birch et al.,
2000; Yerly et al., 2001; Metzker et al., 2002; Bracho et al., 2005),
but it was not until 2013 that a molecular clock approach was ﬁrst
used in evolutionary analysis to conﬁrm HCV transmission from a
single source to multiple patients (González-Candelas et al., 2013).
An effective analysis of this kind requires two critically impor-
tant factors. First, the inclusion of a number of local cases of
sporadic infection caused by a virus of the same genetic lineage.
Second, the characterization of sequences in different genomic
regions of the virus, at least one of which is in a highly variable
region, provided that sufﬁcient time has elapsed to allow new
variations to accumulate (González-Candelas et al., 2013). Hyper-
variable region 1 (HVR1) is an example of such a highly variable
region in HCV; by using the sequences in HVR1 from both donors
and recipients, a very precise analysis may be performed evenwhen
only a short time has elapsed from transmission to sampling.
Although HCV is endemic worldwide, there is a large degree of
geographic variability in its distribution. Countries with the high-
est prevalence rates are located in Africa and Asia. Areas with
lower prevalence include the industrialized nations in North
America, northern and western Europe, and Australia. The global
prevalence of HCV viraemia is estimated at 1.4% (1.2–1.7%) among
adults and 1.1% (0.9–1.4%) in all ages, corresponding to 75 (62–89)
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and 80 (64–103) million people, respectively. In China, a country
that holds one-ﬁfth of the world's population, these rates are at
1.3% and 0.8%, corresponding to 8.9 (2.7–13.4) and 14.8 (4.4–22.3)
million people (Gower et al., 2014). The most common risk factors
for HCV transmission are blood transfusion from unscreened
donors, injection drug use (IDU), unsafe medical injections, and
other healthcare related procedures. Over the past 30 years, IDU
has been the predominant source of new HCV infection in
developed countries, such that in the US and Australia IDU has
accounted for 68% and 80% of current HCV infections, respectively
(Alter, 2002; Dore et al., 2003). In the developing world, limited
information is known about the prevalence of IDU and its
contribution to HCV transmission (Wasley and Alter, 2000). In a
few developed countries, however, high prevalence of HCV has
been also seen in some older age groups. It may indicate a
substantial role of unsafe medical injections as this was thought
to have occurred 30–50 years ago in a few isolated, hyper-endemic
areas (Kiyosawa et al., 1994; Guadagnino et al., 1997; Okayama
et al., 2002). Unsafe medical injections are the major and continu-
ing contribution factor of new HCV infections in many developing
countries such as China and India. In the remote and rural areas of
these countries, sterile medical supplies may be inadequate or in
shortage. Non-professionals often give injections in an unsanitary
setting, and injections are often given to deliver medications that
could otherwise be delivered by the oral route (Hauri et al., 2004).
In such an environment, people may receive multiple contami-
nated injections over the course of a lifetime, incurring a sub-
stantial cumulative risk of HCV infection (Shepard et al., 2005).
Although not ofﬁcially acknowledged, such scenarios are often
reported, characterizing the current HCV epidemics in China with
multiple small-scale outbreaks scattered in different geographic
regions. We strongly believe that the recent rapid increase in new
HCV-infected cases in the country (http://www.chinacdc.cn/tjsj/
fdcrbbg/) could have largely resulted from such scenarios.
In February 2012, a small outbreak of HCV infection affecting
hundreds of people was reported in the Zicheng Township of Zijin
County, Guangdong Province in China. Medical malpractice relating
to improper reuse of needles was suspected as the cause, because
the majority of the patients had received medical care in the same
small clinic. A number of cases had been identiﬁed earlier in 2010,
but this was not formally recognized until many patients went to
Guangzhou City, the capital of Guangdong province, for medication,
after which the outbreak was made known to the public (http://
www.hufﬁngtonpost.com/2012/02/27/hepatitis-c-china-guangdong
_n_1304040.html; http://www.chinadaily.com.cn/china/2012-02/
24/content_14681120.htm). In response to this situation, the central
and provincial governments sent a group of experts to the site to
conduct an investigation and to devise a treatment plan covered by
a government health insurance program. Approximately 400 people
from the community or its vicinity, who had been exposed to this
outbreak, had their blood screened. However, for some reason this
result has not been ofﬁcially reported. In this study, we obtained the
serum samples that remained from the above-described investiga-
tion for an evolutionary analysis to explore the genetic relatedness
of the viral isolates among these patients.
Results
Sequence ampliﬁcation and genotyping
RT-PCR and DNA sequencing were used to characterize HCV
sequences. In 162/192 (84.4%) samples, we obtained HCV
sequences in four genomic regions: core-E1, E1–E2, NS5A, and
NS5B (Fig. S1). In 21/192 (10.9%) samples, we obtained HCV
sequences only in 1–2 regions (Table S1). Collectively, viral isolates
were genotyped in 185/192 (96.4%) samples, of which 66 (35.7%)
belonged to subtype 2a and 116 (62.7%) belonged to subtype 6a.
For three (1.6%) isolates their 50UTR sequences were classiﬁed into
genotype 6 but subtypes were not differentiated. Given a sample
in which HCV sequences were ampliﬁable in several genomic
regions, consistent genotyping results were shown.
Fig. S2 shows eight maximum likelihood (ML) phylogenies used
to genotype 162 HCV isolates, for which sequences were ﬁrst
obtained in both Core-E1 and NS5B regions and then in E1–E2 and
NS5A. In the trees based on Core-E1 and NS5B sequences, many
isolates appear to be genetically identical, which may reﬂect the
same viral sources in the outbreak or carry-over contamination in
the laboratory. To exclude the latter possibility, we further ampli-
ﬁed more variable E1–E2 and NS5A sequences. Since E1–E2
contains HVR1 and NS5A includes V3, both of which are fast
evolving, they should allow us to better differentiate the isolates
that have newly diverged from a recent common ancestor (Penin
et al., 2004). Analyses of E1–E2 and NS5A sequences showed that
isolates of subtype 2a appeared to be more variable than subtype
6a, while E1–E2 sequences better differentiated those from differ-
ent individuals. However, exceptions were observed in four cases:
BL122 (KJ678485) was identical to ZJ15 (KJ678544); and BL228
(KJ678506) was identical to ZJ96 (KJ678577) in their E1–E2
sequences (Fig. S2). These can arise in different isolates that are
derived from the same viral sources. However, new genetic
variations may have been selected after transmission through
hosts. Such variations may be identiﬁed by cloning E1–E2 ampli-
cons and sequencing multiple clones. By sequencing 9–10 clones
for each isolate, we subsequently revealed their differences in
terms of quasi-species (Fig. S3). Similar to the tree based on the
consensus sequences, these quasi-species were more distant from
the BL37 group (KJ678857–KJ678866), which were used to root
the tree, than from each other. They were more closely related
within hosts than among hosts, while a few identical quasi-species
were only seen within hosts.
Analysis of concatenated sequences
To provide an overview of the phylogenetic relationship among
the isolates characterized from the patients in the outbreak, further
phylogenetic analyses were performed by including a number of
local controls and calibrating references (which had their sampling
dates known). Longer sequences are analyzed, more phylogenetic
information may be provided with stronger bootstrap values to
better support the ancestral relatedness of the determined viral
isolates. In addition, analysis of sequences concatenated from
different genomic regions is a way to verify that no viral recombi-
nation is resulted from crossover contaminations, which are other-
wise common and will considerably affect the signiﬁcance of
evolutionary analysis. As a result, two comprehensive ML phyloge-
nies were reconstructed, one for subtype 2a and the other for 6a,
based on the sequences concatenated from four subgenomic
regions: Core-E1, E1–E2, NS5A, and NS5B. The resulting sequences
were each 2227 nucleotides (nt) in length for subtype 2a and 2102
nt for subtype 6a. These included 82 controls that represented the
local HCV-infected population (in which the virus was probably
contracted via sporadic transmission): 24 infected with subtype 2a
strains and 58 infected with 6a strains (Lu et al., 2013). These also
included 103 calibrating references: 68 determined in this study (Lu
et al., 2005; Murphy et al., 2007; Fu et al., 2011, 2012; Gu et al.,
2013; Li et al., 2014) and 35 retrieved from GenBank (Kato et al.,
2001; Kurihara et al., 2001; Noppornpanth et al., 2008; Okamoto
et al., 1991, 1992; Tokita et al., 1994; Zhou et al., 2011).
The two ML trees based on the concatenated sequences are too
large to display and are thus provided in Figs. S4 and S5,
respectively, and both look similar to those presented in Fig. S2.
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Although the sequences from the study patients are distinguish-
able from each other, they form tightly grouped clusters in both
trees. In contrast, the local controls and calibrating references are
mixed to some extent, with the latter appearing to be more
genetically diverse. Two additional features are indicated by the
6a tree: (1) three isolates with the ZJ initials, ZJ60 (KJ678563,
KJ678717 and KJ678960), ZJ72 (KJ678567, KJ678721 and KJ678964)
and ZJ78 (KJ678570, KJ678724 and KJ678967), from the study
patients sampled in the surrounding region, each diverge in a
solitary branch positioned outside the tightly grouped cluster –
they appear to represent sporadic strains (this was also apparent
in Fig. S2); and (2) almost all of the calibrating references from
Vietnam and from Canada are located at the other end of the tree
and are genetically highly diverse.
Evolutionary analysis
Based on the concatenated sequences, the entire E1 and partial
NS5A regions were trimmed for use in the BEAST (Bayesian
Evolutionary Analysis by Sampling Trees) analyses based on three
clock models, exponential, lognormal and strict. We used different
models in an attempt to show that, regardless of the models used,
we would determine similar epidemic histories of HCV for the
study patients – this should demonstrate the robustness of our
approach.
Fig. 1 presents six maximum clade credibility (MCC) trees for
subtype 2a sequences, all of which suggest very similar ancestral
relationships among subtype 2a isolates determined from the
study patients. The closely grouped sequences from the study
patients are in sharp contrast with the local controls, which are
genetically diverse. Scaled by the calibrating references, the ages of
the majority of the isolates from the study patients can be
delimited within 2–5 years before their sampling. In contrast,
the diverse branches of the controls were older and to a certain
extent mixed with the calibrating references that had emerged
even earlier. The closely grouped sequences from the study
patients can be divided into three clusters, “a”, “b” and “c”,
containing 50, 2 and 8 sequences, respectively. The “a” cluster
can be further divided into several small subsets. Using this group
information in further BEAST analyses, their tMRCAs (the time of
the most recent common ancestor) were estimated as 2.7–3.9, 3.1–
3.2 and 3.6–4.4 years for “a”, 2.2–2.7, 2.2–3.2 and 3.5–4.0 years for
“b”, 2.0–4.6, 3.8–4.6 and 3.1–5.0 years for “c”, and 7.4–7.8, 7.7–9.1
and 9.3–9.8 years for the three clusters as a whole, using the
exponential, lognormal and strict models, respectively (Fig. 2).
Fig. 3 depicts six MCC trees based on subtype 6a sequences.
Although the trees may be drawn in different ways, the example of
the trees in this ﬁgure is used for the following description. It was
shown that the sequences from the study patients are all restricted
to the upper parts and markedly right skewed – these sequences
display very short branches that appear to have aligned to the
right ends. In contrast, those from the local controls, most of which
were 410 years old (branch length from the most peripheral node
to the branch end that was measured by the ruler under the tree),
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Fig. 1. Six MCC trees estimated for subtype 2a sequences in the entire E1 and partial NS5A regions, corresponding to the nucleotides numbered 739–1490 and 6822–7664 in
the H77 genome, using the exponential, lognormal and strict clock models. Each tree includes three groups of sequences: 60 from the study patients (blue), 24 local controls
(red), and 32 calibrating references (green). Branch length represents the evolutionary ages measured by the grids corresponding to a reverse timescale at the base of each
tree, starting from the sampling time (right) to the past (left). Three clusters, a, b, and c, indicate the temporarily classiﬁed three subtype 2a lineages determined from the
patients exposed in this outbreak. Prior to these three clusters, a common ancestor is indicated with a magenta circle.
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are distributed largely in the middle and are intermingled with a
fraction of the calibrating references that were sampled in China
(Fu et al., 2011, 2012; Gu et al., 2013; Lu et al., 2005; Zhou et al.,
2011). At the bottom of the trees are distributed another fraction of
the calibrating references that were sampled in Vietnam or from
Asian immigrants living in Canada; many of these sequences were
420 years old (branch length from the most peripheral node to
the branch end) (Murphy et al., 2007; Li et al., 2014; Tokita et al.
1994; Noppornpanth et al., 2008). The 6a sequences from the
study patients can be divided into a large (L) and a small (S) cluster
in addition to three solitary branches. The large cluster contains 93
isolates while the small one includes six. The tMRCAs were
estimated to be 4.0–4.4, 3.5–4.8 and 4.6–4.8 years for cluster (L),
and 2.3–2.3, 2.1–2.8 and 2.3–2.8 years for cluster (S), using the
exponential, lognormal and strict models, respectively (Fig. 2).
Cluster (L) can be also divided into 3–4 small subsets, each
containing a comparable number of isolates, with their node ages
being very similar. Regardless of a few controls that are inter-
spersed between the two clusters and three solitary branches, we
included these sequences as a whole to estimate their tMRCAs,
which were 11.5–14.9, 11.7–14 and 17.3–17.6 years, using the
exponential, lognormal and strict models, respectively (Fig. 2).
The estimated Bayes factor indicated that for both subtype 2a
and 6a the exponential model was better than the lognormal
model, which was in turn better than the strict model (Table S2).
Based on the concatenated sequences, similar BEAST analyses were
also performed. However, because of the heavy computational
burden resulting from a large number of long sequences, the
subtype 6a analyses were difﬁcult to converge and therefore these
results are not included.
Discussion
We characterized the epidemiological relationship among
sequences of HCV determined from 162 patients involved in an
outbreak occurring in southern China in February 2012. We
revealed the robust grouping of subtype 2a and 6a isolates in ﬁve
distinct clusters all showing tMRCAs in 2-5 years before sampling,
independent of the molecular clocks used and genomic regions
sequenced. These distinct clusters may represent separate intro-
ductions of HCV in the population who visited the clinic and
resemble individual isolates of the local background strains that
were otherwise sporadic in this area.
The HCV isolates from the study patients belong to either
subtype 2a or 6a and no other genetic lineages were detected. In a
series of our recent studies, we reported that approximately 75% of
the HCV isolates in China are 1b strains, followed in prevalence
(i.e. at 7.7–14.0%) by subtype 2a (Lu et al., 2005, 2013; Fu et al.,
2011). However, in Guangdong province (the Zhijin county where
this outbreak occurred is in the east of this province) subtype 6a is
increasingly prevalent, detectable in 51.5% of HCV-infected IDUs
(Fu et al., 2012), 49.7% of HCV-infected volunteer blood donors (Fu
et al., 2011), and 17.1% of patients with HCV-related chronic liver
disease (Gu et al., 2013; Lu et al., 2013), along with multiple other
genotypes and subtypes. Although the higher frequency of sub-
type 6a than 2a detected in this study was consistent with the
ﬁndings described above, the complete absence of other HCV
lineages, particularly subtype 1b, was completely unexpected, for
which at least three plausible scenarios exist. First, other HCV
lineages may have been missed because of laboratory errors.
Second, the absence was due to insufﬁcient sampling. Third, both
subtype 2a and 6a have been locally epidemic over a long period of
time and thus predominant over other HCV genetic lineages.
To reduce the ﬁrst possibility, we used a combination of
strategies for HCV genotyping. By following the criteria in the
consensus paper for HCV classiﬁcation (Simmonds et al., 2005;
Smith et al., 2014), we ﬁrst ampliﬁed the Core-E and NS5B
sequences, which yielded the expected amplicons from 177 (i.e.
166 yielded both Core-E and NS5B sequences, and 11 yielded only
NS5B) out of 192 study patients. However, it was possible that the
negativity in 15 patients was due to rare or new HCV genetic
variations. Therefore, we further ampliﬁed a more conserved Core
sequence and the most conserved 50UTR, which yielded positive
results in eight patients (Table S1). Analyses of these sequences
demonstrated the exclusive presence of subtypes 2a and 6a
strains.
It is possible that the sampling was insufﬁcient because we
only tested 192 out of the total 269 HCV-RNA positive patients.
Among the remaining 77 patients who were not included in this
study, other HCV genetic lineages may have been present. In
parallel, aliquots of samples from 193 patients who were positive
for HCV-RNA and lived in a small area (denoted BL) were also
tested by another research group. They reported Core, E1 and/or
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Fig. 2. The tMRCAs estimated for three clusters (a, b, and c) of subtype 2a sequences and two clusters (L and S) of subtype 6a sequences determined from the study patients
and their common ancestors (ANCES) using three clock models, exponential (red), lognormal (green), and strict (yellow). The error bars indicate the 95% highest posterior
density credible intervals.
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Fig. 3. Six MCC trees estimated for subtype 6a sequences in the entire E1 and partial NS5A regions, corresponding to the nucleotides numbered 739–1490 and 6822–7664 in
the H77 genome, using the exponential, lognormal and strict models. Each tree contains three groups of sequences: 102 from the study patients (blue or cyan), 58 from the
local controls (red), and 71 calibrating references. The latter includes three subgroups: 46 from China (green), 15 from Vietnam (purple), and 10 from Canada (yellow). As a
whole, these sequences are divided into four subsets: I, II, III and IV, and many other lineages. Into subset III are classiﬁed all the sequences determined from the study
patients, of which the majority are divided into clusters S and L. Within cluster L, 3–4 internal nodes are marked, each with a magenta circle and a number, which indicate
the ages of the putative earlier 6a strains that had been serially transmitted among patients, likely via the iatrogenic network.
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NS5B sequences detected in 129 patients, showing the similar
exclusive presence of subtype 2a and 6a strains. We did not test 48
patient samples from this set of 129 patients, but their 2a or 6a
sequences have been reported to GenBank with the following
accession numbers: JX194813-5062 and KF926865-982.
Although we were unable to test the third hypothesis in detail
due to the lack of a wide-ranging HCV surveillance program, the
absence of other HCV genotypes and subtypes can be true. Since
there was a free treatment plan covered by a government health
insurance program, every household in this local area was encour-
aged to participate in the epidemiological investigation. We there-
fore believe that the individuals exposed in this outbreak or with
either a pre-existing HCV infection or similar symptoms would all
have been included for HCV screening. Given that the HCV
screening assays used were sufﬁciently sensitive, the exclusive
detection of subtypes 2a and 6a strains could reﬂect a local HCV
epidemic pattern that has become established over years.
Excluding the above-described three plausible scenarios, other
possibilities also exist. For example, due to differences in the
history of viral transmission, particular lineages of HCV may be
predominant in a certain subset of people or prevalent in a speciﬁc
region of a country as we have recently described in China (An
et al., 2014; Fu et al., 2011, 2012; Lu et al., 2014) and reported by
others in Europe (Ansaldi et al., 2005; Dal Molin et al., 2002) and
in Latin America (Ré et al., 2003, 2011; Di Lello et al., 2015).
In the 2a trees, three clusters were consistently adjacent and
formed a larger clade. The age of the common ancestor of this
clade was estimated to be 7.4–9.8 years before sampling, depend-
ing on the clock model used. This time frame suggests an earlier 2a
strain seeded in this local area. After divergence, many genetically
related but distinct descendants could have been generated. As the
iatrogenic transmission proceeded in the local population and
persisted, the infections caused by a few descendant strains would
have been highly selected and accumulated. In other words, some
patients may have accessed the transmission network many times,
which made it likely that they were infected ﬁrst and then passed
the related viral strains to other patients. Although there are fewer
2a cases than 6a examples, they nevertheless comprised a sig-
niﬁcant portion of those in the outbreak.
The accumulated transmission of a few selected HCV strains
from such genetically related but distinct descendants is more
clearly illustrated by the analysis of subtype 6a sequences. This
analysis showed not only phylogenetic clusters analogous to those
of 2a sequences, but also indicated other descendants that did not
appear to be linked to the outbreak. In the trees, all 6a sequences
from the study patients formed one large and one small cluster in
addition to three solitary branches that were all classiﬁed into a
tentatively designated 6a group, group III (Fu et al., 2011, 2012; Gu
et al., 2013). However, if we compress the two clusters into two
single branches, it is evident that this group III is consistently
formed by ﬁve branches from the study patients, 10 branches of
the local controls and two branches of the calibrating references.
This indicates that at least ﬁve related descendant strains of 6a
group III have been circulating in this area, which may indicate a
long-term local epidemic circulation. We hypothesize that,
because of medical malpractice, two such strains emerged, became
highly selected and spread efﬁciently through the iatrogenic net-
work, causing the majority of cases in the outbreak. In contrast,
the other three strains were sporadically distributed, but were
only seen in the surrounding region. Based on these trees, we were
able to estimate the tMRCAs that preceded the two clusters and
the three solitary branches, although they were interspersed with
a few local controls. For subtype 6a strains, the tMRCAs were 4–6
years longer than the 2a counterparts. These estimates may
indicate a period when an earlier strain of 6a group III was ﬁrst
introduced into this local area. After divergence, related but
distinct descendants were generated, ﬁve of which were detected
in this study. There could be additional 6a strains in this local area
that were not detected. Characterization of such strains requires
more extensive HCV surveillance to be performed in a wider range
of region including this local area, which will allow us to assess the
likelihood of why these otherwise efﬁciently transmitted 6a
strains were not detected in this outbreak.
With reference to two other equally important blood-borne
pathogens, HBV and HIV-1, it is known that the former has shown
a much higher prevalence than HCV in the general population in
China (He et al., 2005), while the latter has now entered a
generally disseminated stage (Saksena et al., 2005). Strikingly, no
similar outbreaks of HBV and HIV-1 infections were observed in
the same area and during the same period. For HBV, this is likely
for two reasons: (1) the national HBV immunization program,
which has resulted in a drastic decrease of the incidence of new
HBV infections in the country, particularly in Guangdong province
(Xiao et al., 2012) in which the described outbreak of HCV
infection occurred; and (2) possible saturation of HBV infection
in the general population, as suggested by the relatively constant
sero-prevalence of HBV markers (HBsAg and anti-HBs) in a
Chinese IDU cohort over ﬁve years (Garten et al., 2004). Concern-
ing the potential spread of HIV-1, this agent has shown 50–100
times lower infectivity than HBV and HCV and much lower
prevalence in the general population in the country (World
Health Organization, 2011). Regardless, there was an outbreak of
HIV transmission in neighboring Cambodia last year, which
affected Z200 inhabitants of a rural village. An unlicensed doctor
who reused syringes and other medical equipment was charged
with spreading the infection. Unfortunately, in such a rural area of
extreme poverty and lax law enforcement, it is not yet known how
widespread the reusing of needles is and whether this will cause a
tragedy to happen (http://www.nytimes.com/2015/01/20/world/
asia/farming-village-in-cambodia-grieves-as-hundred
s-learn-they-have-hiv.html?_r=0).
The transfusion of contaminated blood or blood products was
the main route of HCV transmission in China before 2000. Since
the implementation of volunteer blood donors and the outlawing
of paid blood donation in 1998, IDU and unsafe medical practice
have become the major transmission routes (Fu et al., 2012).
Nevertheless, in the consecutive four years before and up to this
2012 HCV outbreak, the number of newly reported HCV-infected
cases in China continued to surge, with annual increases of 21.58%,
16.07%, 13.61% and 15.96%, respectively, such that the total
reported new cases increased from 108,446 in 2008 to 201,622
in 2012 (http://www.chinacdc.cn/tjsj/fdcrbbg/). Among these
cases, a large number of patients may have acquired HCV infec-
tions in similar outbreaks occurred in other regions. For example,
an outbreak was reported in December 2011, in a region adjoining
the Danchen Township of Guoyang County in Anhui Province and
the Maqiao Township of Yongcheng City in Henan Province (http://
hzdaily.hangzhou.com.cn/dskb/html/2011-12/01/content_1181001.
htm?jdfwkey=yujoo3). More than 400 people were affected,
including many children, all of whom had received injections in
a clinic in which the doctors reused needles. A second outbreak
occurred in November 2012 in Fengyang County, which is also in
Anhui Province. Approximately 200 people were affected, all of
whom had visited a clinic in the Chezhan Village of Banqiao
Township. The doctors there reused needles and intravenous drip
bottles (http://health.dir.groups.yahoo.com/neo/groups/hepcan/
conversations/topics/42852). A similar event also occurred in June
2012 in Xuyong County of Sichuan Province, but the patient
number remains unknown (http://news.lzep.cn/2012/0612/
70228.html). Additional events are suggested by the high pre-
valence of anti-HCV reported in some populations. For example, in
a village in Putian City of Fujian Province, the anti-HCV prevalence
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was as high as 29% among people Z2 years old. However, this
prevalence appeared to not be linked to blood donation, transfu-
sion or IDU (http://health.people.com.cn/GB/15521324.html).
Based on our personal observations, a similar scenario may also
characterize a region adjoining Shizong County and Luxi County in
Yunnan province. In Zhehei Village and its surrounding region, we
believe that an HCV epidemic of considerable scale has persisted
for years, affecting nearly a thousand people, with many families
having more than one patient. Most individuals affected have
complained of receiving unsterilized injections from clinics in the
village.
These ﬁndings illustrate the continuing spread of HCV in Asian
countries due to unsterile injections or contaminated medical
equipment. The reporting of other events in China is very educa-
tional for people from the western world who start to believe that
nosocomial HCV transmission is something that belongs in the
past. In fact, China is not the only country with infection control
problems. Other countries such as India, Pakistan, and the central
Asian countries of the former Soviet Union are all faced with the
same problem where the battle against HCV is not easily won if
medical standards do not improve.
Materials and methods
Serum samples from studied patients
Serum samples from the studied patients were surplus to the
requirements of the epidemiological investigation described
above. After collection, these samples were sent to the Third
Afﬁliated Hospital of Sun Yat-sen University to screen for anti-
HCV antibodies (ELISA kit, Kehua Biotech Co. Ltd., Shanghai, China)
and HCV RNA (Roche AmpliPrep/Cobas TaqMan HCV Assay version
2, Roche Molecular Systems, Pleasanton, CA), which identiﬁed 269
patients positive for both markers. Of these 269 patients, 193 lived
in a small area (denoted BL) along Xiangshui Street, while 76 lived
in the surrounding region (denoted ZJ). There were sufﬁcient
samples (one from each patient) for use in this study (Fig. 1) from
192 patients (87 males and 105 females), with an age range of 3–
90 and mean age of 44.2718.4. Written informed consent was
obtained from all patients. The ethical review committee of the
Third Afﬁliated Hospital of Sun Yat-sen University approved this
study based on the provisions of the Declaration of Helsinki.
Serum samples from local controls
As local controls (individuals who may have acquired HCV
infection due to sporadic transmission other than in an outbreak),
archived serum samples from 24 patients infected with HCV
subtype 2a strains and 58 patients infected with subtype 6a
strains were also used in this study (Fig. 1). We had previously
collected these samples during 2009–2011 from patients who
sought medication at the Third Afﬁliated Hospital of Sun Yat-sen
University; both Core-E1 and NS5B sequences of HCV have
recently been reported for these patients (Lu et al., 2013).
Serum samples for calibrating sequences
To calibrate the timescale over which HCV has circulated and
diversiﬁed, sequences of 32 subtype 2a strains and 71 subtype 6a
strains, for which the sampling dates are known, were used as
calibrating references (Figs. S4 and S5). Among them, 15 of subtype
2a and 53 of subtype 6a strains were sequenced in this study using
archived serum samples that we had collected during the years
2002–2011 or kindly provided by our collaborators (Okamoto
et al., 1991; Lu et al., 2005; Murphy et al., 2007; Fu et al., 2011,
2012; Gu et al., 2013; Li et al., 2014).
Sequence ampliﬁcation and characterization
HCV sequences were ampliﬁed in six subgenomic regions,
50UTR, Core, Core-E1, E1–E2, NS5A, and NS5B, using the protocols
previously described (Lu et al., 2005) and the primers listed in
Table S3. To obtain consensus sequences, all amplicons were
directly sequenced in both directions. Any errors in base calling
were corrected using the SeqMan program, and the sequences
were edited using the EditSeq program followed by alignment
using the MegAlign program (DNASTAR Inc., Madison, WI). To
characterize the higher genetic variation in the E1–E2 region,
selected amplicons were cloned followed by plasmid sequencing
(Lu et al., 2008). All ﬁnalized sequences, together with reference
sequences, were classiﬁed by phylogenetic analyses, for which the
most appropriate substitution model GTRþ IþΓ4 (General time-
reversible with invariable-sites-plus-gamma) was selected using
the jModeltest program (Posada, 2008) and the ML phylogenies
were heuristically searched using the PhyML program (Guindon
and Gascuel, 2003).
Evolutionary analysis
Sequences spanning the entire E1 and partial NS5A regions
were assembled based on HCV subtypes with the inclusion of local
controls and calibrating references. Evolutionary analyses were
performed using the Bayesian MCMC (Markov chain Monte Carlo)
algorithm implemented in the BEAST package (version 1.6.1)
(Drummond & Rambaut, 2007) under the default prior setting
except that GTRþ IþΓ substitution model and the Bayesian sky-
line coalescent model were selected in combination with one of
the three clock models: the exponential, lognormal and strict
models. For the exponential model, this was done by ﬁrst
estimating the calibrating sequences to obtain such a rate followed
by an inclusion of the rate as a prior in the subsequent analysis of a
given dataset. For the latter two models, however, the analyses
used the prior evolutionary rates (Table S2). In setting the Bayesian
skyline coalescent model, different prior numbers were tested for
different datasets using different clock models until all the poster-
iors reached the effective sampling size of Z200. The MCMC
analysis was run for 100–500 million steps, outputting a tree every
20,000–30,000 steps. To interpret the chain lengths, the Tracer
(version 1.5) program was used, which was also used to calculate
the Bayes factor for comparing the analyses under different
models, to summarize the tMRCAs and to delimit the 95% HDP
(highest posterior density credible intervals). Lastly, we used the
TreeAnnotator program (version 1.6.1) to summarize a tree from
the resulting set of credible trees, which is called the MCC tree.
Since a molecular clock was incorporated, the branch lengths and
the tree node heights were marked in units of years. Phylogenetic
structure was then displayed using the FigTree program, in which
clades, lineages and internal node heights were indicated as
required.
Nucleotide sequence accession numbers
The nucleotide sequences reported in this study were depos-
ited in GenBank with the following accession numbers: KJ678155–
KJ678975, KJ700856–KJ700861, and KM502262–KM502265 (Figs.
S4 and S5).
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